House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Neurology · Emergency medicine

Early management of acute ischaemic stroke

AHA / ASA · 2026 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

The AHA/ASA official highlights describe selected updates in early acute ischaemic stroke care, from transport and reperfusion selection to physiological management. They include broader eligibility for some interventions but do not supply a complete bedside treatment protocol.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Organize timely stroke care

  • The guideline supports implementation of mobile stroke units when available, reflecting evidence of safe and beneficial earlier identification and treatment of thrombolysis-eligible patients. [1]
  • Choose the prehospital destination in light of the local stroke system. Consider direct transport to the closest thrombectomy-capable hospital when a well-functioning system with rapid interhospital transfer is absent. [1]

Match reperfusion treatment to deficits and timing

  • Either alteplase or tenecteplase is endorsed within the 4.5-hour intravenous thrombolysis window. The highlight does not specify doses or all eligibility criteria. [1]
  • Treat eligible patients with disabling deficits rapidly within 4.5 hours, irrespective of NIHSS score, without requiring advanced-imaging selection in that window. [1]
  • Selected patients with unknown onset or onset 4.5–9 hours earlier may be considered for extended-window thrombolysis using advanced-imaging criteria, such as diffusion–FLAIR or perfusion mismatch. The selection criteria must not be generalized to all late presenters. [1]
  • For non-disabling deficits, such as an isolated sensory syndrome, within 4.5 hours, dual antiplatelet therapy is preferred and recommended. Trials have not demonstrated benefit from thrombolysis in this population. [1]
  • Do not add adjuvant antithrombotic drugs to improve thrombolysis outcomes. Studies of concurrent agents such as argatroban and eptifibatide did not show benefit. [1]

Identify expanded thrombectomy candidates

  • Endovascular thrombectomy is established for acute stroke with large-vessel occlusion. New evidence supports benefit in some patients with larger ischaemic cores defined by imaging; the highlight does not give a universal large-core eligibility rule. [1]
  • There is a strong recommendation for thrombectomy in basilar artery occlusion when presentation is within 24 hours of symptom onset and NIHSS is at least 10. Both the timing and severity conditions are part of this recommendation. [1]
  • The guideline now includes paediatric interventional recommendations. It emphasizes early recognition and supports potential safety and benefit of endovascular intervention in selected children, rather than establishing eligibility for all paediatric strokes. [1]

Avoid unsupported intensive physiological targets

  • Do not use intensive glucose control to 80–130 mg/dL to improve stroke outcome; this approach increases severe hypoglycaemia risk. [1]
  • In adults after intravenous thrombolysis or endovascular thrombectomy, intensive systolic blood-pressure lowering below 140 mmHg is not recommended, even after complete reperfusion. More intensive reduction has not improved function after intravenous thrombolysis and may harm patients after thrombectomy. [1]

Limitations and use

  • This covers the official Top Things to Know selection, not the complete guideline. Drug doses, complete eligibility and exclusion criteria, imaging thresholds and detailed blood-pressure targets outside the stated recommendation are not provided. The paediatric statements do not define a complete paediatric intervention protocol.
  • This House summary is based on the linked focused or condensed recommendation sources; it does not represent the complete original publication.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Early management of acute ischaemic stroke — focused recommendation source

    Selected recommendation material consulted

Original guideline

Publication details

Issuing organisation
AHA / ASA
First published
26 January 2026
Resource type
Clinical guideline · House clinical summary

Earlier House summaries: acute ischaemic stroke aha

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Organize timely stroke care
  • Match reperfusion treatment to deficits and timing
  • Identify expanded thrombectomy candidates
  • Avoid unsupported intensive physiological targets
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House